David Francis Sells 2,000 Shares of Maximus Inc. (MMS) Stock
Maximus Inc. (NYSE:MMS) General Counsel David Francis sold 2,000 shares of Maximus stock in a transaction that occurred on Friday, October 14th. The shares were sold at an average price of $55.00, for a total value of $110,000.00. Following the sale, the general counsel now directly owns 29,616 shares in the company, valued at $1,628,880. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
David Francis also recently made the following trade(s):
- On Thursday, September 1st, David Francis sold 1,500 shares of Maximus stock. The shares were sold at an average price of $58.69, for a total value of $88,035.00.
- On Monday, August 1st, David Francis sold 1,500 shares of Maximus stock. The shares were sold at an average price of $58.91, for a total value of $88,365.00.
Maximus Inc. (NYSE:MMS) opened at 53.98 on Tuesday. The stock has a 50 day moving average of $56.78 and a 200-day moving average of $55.98. The company has a market cap of $3.50 billion, a PE ratio of 22.06 and a beta of 1.15. Maximus Inc. has a 1-year low of $45.15 and a 1-year high of $69.85.
Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 4th. The company reported $0.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.04. The firm had revenue of $617.10 million for the quarter, compared to analysts’ expectations of $625.62 million. Maximus had a net margin of 6.91% and a return on equity of 23.89%. The business’s revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 EPS. On average, equities research analysts predict that Maximus Inc. will post $2.65 earnings per share for the current year.
A number of equities research analysts have weighed in on MMS shares. Zacks Investment Research downgraded Maximus from a “hold” rating to a “sell” rating in a report on Wednesday, August 3rd. KeyCorp started coverage on Maximus in a report on Thursday, June 30th. They set an “overweight” rating and a $63.00 price objective on the stock. Finally, Maxim Group lifted their price objective on Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a report on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $63.00.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Navellier & Associates Inc bought a new position in Maximus during the second quarter valued at $208,000. Parametrica Management Ltd bought a new position in Maximus during the second quarter valued at $216,000. LS Investment Advisors LLC boosted its position in Maximus by 70.9% in the second quarter. LS Investment Advisors LLC now owns 3,928 shares of the company’s stock valued at $217,000 after buying an additional 1,630 shares in the last quarter. BW Gestao de Investimentos Ltda. boosted its position in Maximus by 28.6% in the second quarter. BW Gestao de Investimentos Ltda. now owns 4,994 shares of the company’s stock valued at $277,000 after buying an additional 1,110 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Maximus by 51,180.0% in the second quarter. Tower Research Capital LLC TRC now owns 5,128 shares of the company’s stock valued at $284,000 after buying an additional 5,118 shares in the last quarter. 99.00% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.